TopFunds

Elevance Health

NYSE: ELV

Stock price

400.94 USD

(+0%) TODAY

Managed Health CareMedical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
9.4
9.2
14.4
14.2
18.5
18
24.7
24.3
25.2
25.7
25.1
10.4%
02Free cash flow per share
12.9
9.8
12.7
10.3
19.1
38
29.5
29.8
28.5
19.5
14.3
1.1%
03Dividends per share
2.5
2.6
2.7
3
3.2
3.8
4.5
5.1
5.9
6.5
6.8
10.6%
04Dividends payout, %
25.7%
27.7%
18.3%
20.7%
17%
20.9%
18.1%
20.9%
23.3%
25.2%
27%
0.5%
PROFIT AND LOSS STATEMENT
05Revenue
79,240
84,978
90,039
92,105
104,213
121,867
138,639
156,595
171,340
176,810
199,125
9.7%
06% Change
-
-
-
-
-
-
-
-
-
-
-
9.7%
07Cost of revenue
(61,117)
(66,834)
(72,236)
(71,895)
(81,786)
(88,045)
(102,645)
(116,642)
(124,330)
(127,567)
(148,223)
9.3%
08Gross profit
18,123
18,144
17,803
20,210
22,427
33,822
35,994
39,953
47,010
49,243
50,902
10.9%
09% Margin
22.9%
21.4%
19.8%
21.9%
21.5%
27.8%
26%
25.5%
27.4%
27.9%
25.6%
24.3% A
10Operating expenses
(12,765)
(12,725)
(12,818)
(14,373)
(15,694)
(26,111)
(27,048)
(31,502)
(38,265)
(40,355)
(42,790)
12.9%
11% of Revenue
(16.1)%
(15)%
(14.2)%
(15.6)%
(15.1)%
(21.4)%
(19.5)%
(20.1)%
(22.3)%
(22.8)%
(21.5)%
(18.5)% A
12Operating Income
5,358
5,419
4,985
5,837
6,733
7,711
8,946
8,451
8,745
8,888
8,112
4.2%
13Income tax expense
(2,071)
(2,086)
(121)
(1,318)
(1,178)
(1,666)
(1,830)
(1,712)
(1,724)
(1,933)
(1,049)
(6.6)%
14Net Income
2,560
2,470
3,843
3,750
4,807
4,572
6,104
5,894
5,987
5,980
5,662
8.3%
15% Margin
3.2%
2.9%
4.3%
4.1%
4.6%
3.8%
4.4%
3.8%
3.5%
3.4%
2.8%
3.7% A
16Shares Outstanding
272.9
268.1
267.8
254.3
260.3
254.3
246.8
242.8
237.4
232.9
221.8
(2.1)%
17EPS Basic
9.7
9.4
14.7
14.5
18.8
18.2
25.3
24.6
25.4
25.8
25.2
10%
18EPS Diluted
9.4
9.2
14.4
14.2
18.5
18
24.7
24.3
25.2
25.7
25.1
10.4%
19EBITDA
6,192
6,190
5,593
6,953
7,864
8,176
10,025
10,126
10,490
10,482
9,658
4.6%
% Margin
7.8%
7.3%
6.2%
7.6%
7.6%
6.7%
7.2%
6.5%
6.1%
5.9%
4.9%
6.7% A
20Net Interest Income (expense)
(653)
(723)
(739)
(753)
(746)
(784)
(798)
(851)
(1,030)
(1,185)
(1,402)
7.9%
21Net Debt / EBITDA
2.2
1.9
2.9
2.2
2.1
2
2
1.8
1.9
2.3
2.5
2.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,114
4,075
3,609
3,934
4,937
5,741
4,880
7,387
6,526
8,288
9,491
16.2%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
4,603
5,861
6,185
6,743
7,584
8,128
9,691
11,746
12,460
13,055
15,235
12.7%
25Other current assets
-
-
-
-
-
-
-
-
-
-
-
-
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
6,716
9,936
9,794
10,677
12,521
13,869
14,571
19,133
18,986
21,343
24,726
13.9%
Non-Current Assets
28Net property, plant & equipment
2,020
1,978
2,175
2,735
3,708
4,129
4,547
4,920
4,943
5,219
5,131
9.8%
29Long-term investments
21,011
21,444
24,931
22,452
25,461
29,839
34,005
33,342
36,826
37,177
38,584
6.3%
30Other non-current assets
33,314
33,029
34,560
36,606
36,564
40,439
44,337
45,360
48,173
53,150
53,053
4.8%
31Total Non-Current Assets
56,345
56,451
61,666
61,793
65,733
74,407
82,889
83,622
89,942
95,546
96,768
5.6%
Total Assets
63,061
66,387
71,460
72,470
78,254
88,276
97,460
102,755
108,928
116,889
121,494
6.8%
LIABILITIES
Current Liabilities
32Accounts payable
7,570
7,893
7,992
7,454
8,842
11,359
13,518
15,596
16,111
15,746
17,084
8.5%
33Short-term debt
540
1,368
2,550
1,994
2,456
810
2,007
1,946
2,038
2,167
1,380
9.8%
34Other current liabilities
-
-
-
-
-
-
-
1,112
1,402
1,508
1,493
10.3%
35Total Current Liabilities
8,110
9,261
10,541
9,448
11,298
12,169
15,525
18,654
19,551
19,421
19,957
9.4%
Non-Current Liabilities
36Long-term debt
15,325
14,359
17,382
17,217
18,751
21,029
22,885
23,851
24,616
30,534
31,855
7.6%
37Other non-current liabilities
16,583
17,667
17,034
17,264
16,477
21,879
22,922
23,920
25,356
25,508
25,656
4.5%
38Total Non-Current Liabilities
31,907
32,026
34,416
34,481
35,228
42,908
45,807
47,771
49,972
56,042
57,511
6.1%
39Total Liabilities
40,017
41,287
44,957
43,929
46,526
55,077
61,332
66,425
69,523
75,463
77,468
6.8%
SHAREHOLDERS` EQUITY
40Common stock
2.6
2.6
2.6
3
3
3
2
2
2
2
2
(2.6)%
41Retained earnings / (deficit)
14,779
16,561
18,054
19,988
22,573
23,802
27,088
29,647
31,749
33,549
35,393
9.1%
42Accumulated other comprehensive income / (loss)
(292.6)
(267.9)
(101.5)
(986)
(296)
150
(178)
(2,490)
(1,313)
(1,147)
(451)
4.4%
43Noncontrolling interests
-
-
-
-
-
-
68
87
99
111
144
20.6%
44Total shareholders' equity
23,044
25,100
26,503
28,541
31,728
33,199
36,128
36,330
39,405
41,426
44,026
6.7%
45Total Liabilities and shareholders' Equity
63,061
66,387
71,460
72,470
78,254
88,276
97,460
102,755
108,928
116,889
121,494
6.8%
46Total Debt
15,865
15,727
19,932
19,211
21,207
21,839
24,892
25,797
26,654
32,701
33,235
7.7%
47Net Debt
13,751
11,652
16,323
15,277
16,270
16,098
20,012
18,410
20,128
24,413
23,744
5.6%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
2,560
2,470
3,843
3,750
4,807
4,572
6,104
5,894
5,987
5,980
5,662
8.3%
49Depreciation & amortization
907.9
911.8
890.4
1,127
1,133
1,154
1,302
1,675
1,745
1,393
1,546
5.5%
50Share-based compensation expense
148.2
164.6
169.6
226
294
283
255
264
289
191
276
6.4%
51Changes in working capital and other assets
499.9
(341.7)
(718)
(1,276)
(173)
4,679
703
566
40
(1,756)
(3,194)
-
52Net cash flows from operating activities
4,116
3,205
4,185
3,827
6,061
10,688
8,364
8,399
8,061
5,808
4,290
0.4%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(602.9)
(583.6)
(790.2)
(1,208)
(1,077)
(1,021)
(1,087)
(1,152)
(1,296)
(1,256)
(1,116)
6.4%
54Purchases of investments / marketable securities
(11,896)
(12,102)
(16,375)
(9,671)
(22,954)
(19,492)
(18,669)
(24,946)
(16,236)
(17,986)
(15,026)
2.4%
55Proceeds from maturities of marketable securities
11,780
11,952
13,526
11,600
21,035
16,059
14,613
22,608
13,536
18,572
15,095
2.5%
56Other investing activities
(432.7)
219
(1,443)
(1,980)
204
(2,870)
(4,495)
(1,070)
(1,576)
(4,497)
(297)
(3.7)%
57Net cash flows from investing activities
(1,152)
(513.9)
(5,082)
(1,259)
(2,792)
(7,324)
(9,638)
(4,560)
(5,572)
(5,167)
(1,344)
1.6%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(1,516)
(67)
(1,998)
(435)
(1,701)
(2,700)
(1,900)
(2,316)
(2,676)
(2,900)
(2,605)
5.6%
59Dividends paid, net
(656.6)
(684)
(704.9)
(776)
(818)
(954)
(1,104)
(1,229)
(1,395)
(1,508)
(1,529)
8.8%
60Debt issuance (repayments), net
(892.3)
360
3,724
(849)
608
188
2,343
1,795
739
5,562
2,327
-
61Other financing activities
67.3
(341.9)
(594.5)
(181)
(355)
899
1,084
432
(17)
39
69
0.3%
62Net cash flows from financing activities
(2,997)
(732.9)
426.9
(2,241)
(2,266)
(2,567)
423
(1,318)
(3,349)
1,193
(1,738)
(5.3)%
63Increase (decrease) in cash and cash equivalents
(38.2)
1,962
(466.4)
325
1,003
804
(861)
2,507
(861)
1,762
1,203
-
64Cash and equivalents, ending balance
2,114
4,075
3,609
3,934
4,937
5,741
4,880
7,387
6,526
8,288
9,491
16.2%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
3,513
2,621
3,395
2,619
4,984
9,667
7,277
7,247
6,765
4,552
3,174
(1)%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Elevance Health (ELV) financial statements and performance

Explore Elevance Health (ELV) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.